Introduction
Coronavirus disease (COVID-19) is a deadly disease which continues to affect many countries in the world. This is caused by the new coronavirus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which has become a serious public health concern worldwide [
1]. The World Health Organization (WHO) declared the COVID-19 outbreak as a pandemic on 11 March 2020 [
2]. At the time of writing (6 February 2021), this pandemic has affected 223 countries, with over 104.37 million confirmed cases and 22.71 million deaths recorded globally [
3]. The incidence is higher in the Americas (46,313,540 cases and 1,072,244 deaths) and Europe (35,003,091 cases and 767,235 deaths) than in South East Asia (12,982,540 cases and 199,668 deaths), Africa (2,616,892 cases and 64,473 deaths) and the Western Pacific (1,466,248 cases and 25,526 deaths) [
3]. The first COVID-19 case in Bangladesh was reported on 8 March 2020 [
4,
5]. Since then, the numbers of new cases have been rising rapidly in the country. As of 6 February 2021, the country has recorded 537,465 positive cases of COVID-19 and 8182 deaths domestically [
6].
Vaccines are the most important public health measure and most effective strategy to protect the population from COVID-19, since SARS-CoV-2 is a highly contagious virus and affects populations globally. The competition for COVID-19 vaccine invention and development against the spread and catastrophic effects of the disease is ongoing [
7,
8], and new, more effective vaccines are likely to be developed as we move through the pandemic. With the distribution of vaccines underway, it is very important to examine community acceptance of COVID-19 vaccinations [
9]. Bangladeshi authorities agreed to use the Covidshield vaccine from India on 27 January 2021 and Runu (a nurse) became the first COVID-19 vaccine recipient in Bangladesh [
10]. But there is a great controversy about COVID-19 vaccinations among the general population of Bangladesh. A proportion of the Bangladeshi population are hesitating to take the vaccine from India lest they should be infected [
11]. A global survey of potential COVID-19 vaccine acceptance shows that 48% of their study population were confused about the COVID-19 vaccinations and remained unsure about whether they would have the vaccination [
12]. Similarly, a Chinese study found that only just over half of their participants (54.%) said that they intended to have the vaccination [
13]. These relatively low proportions of people willing to have the vaccine are potentially worrying, since although the most effective measure of controlling the spread of the virus is to protect oneself from being exposed to COVID-19, it is also necessary to vaccinate the general people as soon as possible [
14].
In order to implement the most effective vaccination strategy in Bangladesh, we need to know the knowledge, attitudes and perceptions of Bangladeshi people about COVID-19 vaccinations. This is because, people’s knowledge, attitudes and perceptions towards COVID-19 are crucial for Government and policy makers to address all barriers to vaccine distribution. To date, there has been no prior study among the general population of Bangladesh investigating their knowledge, attitudes and perceptions towards COVID-19 vaccine.
Methods
Participants and procedure
An exploratory and anonymous population-based e-survey was conducted among individuals aged 18 years and above distributed via snowball recruitment. The survey was conducted from December 2020 to February 2021, coinciding with the implementation of COVID-19 vaccinations programs in other parts of the world. Thus, rather than being a hypothetical study of knowledge, attitudes and perceptions, our study aimed to capture real-world evidence to inform policy makers and practitioners in Bangladesh in terms of how best to implement our vaccination program. A semi-structured questionnaire was designed and incorporated into the Google survey tool (Google Forms) and a shareable link was generated and disseminated publicly on various social media outlets (e.g., Facebook, WhatsApp, etc.). Likewise, the link was also shared personally to the contact lists of the investigators and research assistants. For data collection, the investigators used online approaches (as opposed to face-to-face data collection) because of maintaining spatial distancing and proper precaution during the pandemic. Initially, 1738 respondents submitted their responses via e-survey. Of them, 1658 respondents (55.6% males; mean age = 23.17 ± 6.05; age range = 18–65 years) completed the entire survey. Rest of respondents (
n = 80) were submitted blank/incomplete survey forms and were excluded from the final analysis. The inclusion criteria of participants were i) being a Bangladeshi resident, ii) being an adult (≥ 18 years old), iii) having internet access, and iv) providing consent. The exclusion criteria included being under 18 years old and incomplete surveys. The study was conducted following the Checklist for Reporting Results of Internet ESurveys (CHERRIES) guidelines [
15].
Sampling procedure
The sample size was calculated using the following Eq. (
1):
$$ {\displaystyle \begin{array}{c}n=\frac{z^2 pq}{d^2}\\ {}\Rightarrow \kern0.5em n=\frac{1.96^2\times .5\times \left(1-.5\right)}{.05^2}\\ {}\Rightarrow \kern0.5em n=384.16\approx 384\end{array}} $$
(1)
Here,
n = number of samples
z = 1.96 (95% confidence level)
p = prevalence estimate (50% or .5) (as no study found)
q = (1-p)
d = precision limit or proportion of sampling error (.05)
As there is no prior similar study focusing on knowledge, attitudes and perceptions regarding the COVID-19 vaccine in Bangladesh, we made the best assumption (p) for the present study would be 50%. Assuming a 10% non-response rate, a sample size of 423.5 ≈ 424 participants was estimated. Our sample size exceeded this estimate.
Measures
A semi-structured and self-reported questionnaire containing informed consent along with four sections (i.e., socio-demographics, knowledge, attitudes, and perceptions) was utilized during data collection (see questionnaire in Additional file
1).
Some questions related to socio-demographics were asked during the survey including age (later categorized as young [18–25 years] and adult [> 25 years] [
16,
17];), sex (male/female), marital status (married/unmarried), educational status (college or below/university or higher), family type (nuclear [two parents and their children]/joint [family unit with more than two parents, extended family] [
18];), monthly family income (later categorized: lower socioeconomic status (SES) < 15,000 Bangladeshi Taka [BDT], middle SES 15,000–30,000 BDT and upper SES > 30,000 BDT) [
19,
20], and current residence (rural/urban). In addition, another “yes/no” question was asked about their previous history of taking all the recommended vaccines (i.e.,
Have you received all the necessary vaccines in your lifetime?).
Knowledge, attitudes, and perceptions
To assess the level of knowledge, attitudes, and perceptions of the respondents, a total of 18 items that were structured questions (including 6-items for knowledge, 6-items for attitudes and 6-items for perceptions). All questions were based on validated questions in previous literature [
21‐
24].
The knowledge section comprised 5-items with three possible responses (i.e.,
“Yes”, “No” and
“Don’t know”) (e.g.,
Does vaccination increase allergic reactions?) (see details in Table
2). The ‘
yes’ response was coded as 1, while the ‘
No/ Don’t know’ responses were conducted as 0. The total score was obtained by summating the raw scores of five items and ranged from 0 to 5, with the higher score indicating the greater level of knowledge towards COVID-19 vaccinations. The Cronbach alpha of knowledge items was 0.68. In addition, an additional question was asked about the source of their knowledge about COVID-19 vaccines (i.e.,
How you came to know about COVID-19 vaccines first?) with some possible answers (e.g., mass media [radio/television], newspaper, internet, social media [Facebook, Twitter], family and relatives, friends and neighbors). The answers to this question are useful for policy makers in terms of disseminating COVID-19 vaccination information in the future in Bangladesh.
The attitude section consisted of 6-items (e.g.,
The newly discovered COVID-19 vaccine is safe; I will take the COVID-19 vaccine without any hesitation, if it is available in Bangladesh.), and the response of each item was indicated on a three-point Likert scale (i.e.,
0 = Disagree, 1 = Undecided, and
2 = Agree) (see details in Table
5). The total score was calculated by summating the raw scores of the six items ranging from 0 to 12, with an overall greater score indicating more positive attitudes towards COVID-19 vaccine. The Cronbach alpha of attitudes items was 0.77.
The perceptions section included 6-items regarding participant’s perceptions towards the COVID-19 vaccine, including 4 items as “yes/no” questions (e.g.,
Do you think the vaccine should be administered free of charge in Bangladesh?) and additional 2 items related to the application of COVID-19 vaccine (e.g.,
Which population groups should be prioritized for vaccinations?) (see details in Table
6).
Statistical analysis
The data analysis was performed using Microsoft Excel 2019 and SPSS version 25.0 (Chicago, IL, USA). Microsoft Excel was used for data cleaning, editing, sorting, and coding. The excel file was then imported into SPSS software. Descriptive statistics (i.e., frequencies, percentages, means, standard deviations) and first-order analysis (i.e., chi-square tests, Fisher’s exact tests) were performed. Likewise, t-tests or one-way ANOVA tests were performed to determine significant relations of the mean knowledge and attitudes scores with socio-demographic information. Finally, factors that significantly differed in terms of knowledge and attitudes scores, were included into multiple linear regression analysis with knowledge and attitudes, respectively. All statistical tests were considered significant at 95% confidence interval with a p-value less than .05.
Ethical consideration
All procedures of the present study were carried out in accordance with the principles for human investigations (i.e., Helsinki Declaration) and also with the ethical guidelines of the Institutional research ethics. Formal ethics approval was granted by the Biosafety, Biosecurity and Ethical Clearance Committee, Jahangirnagar University, Savar, Dhaka-1342, Bangladesh [BBEC, JU/ M 2021 COVID-19/2(2)]. Participants in the study were informed about the procedure and purpose of the study and confidentiality of information provided. All participants consented willingly to be a part of the study during the data collection periods. All data were collected anonymously and analyzed using the coding system.
Discussion
In order to halt the ongoing pandemic, the COVID-19 vaccine has been framed as the ideal solution. Substantial numbers of vaccine candidates are being developed and several clinical trials have recently been released with positive results, leading to a number of countries approving specific vaccines for implementation in vaccination programs. In Bangladesh, the government has already started the COVID-19 vaccination roll-out [
25], bringing hope as part of a pandemic solution. Although there are numerous vaccination services in Bangladesh, the complete newness of the COVID-19 vaccination roll-out poses questions about the distribution and acceptance of vaccines in this country. It also poses questions about the general population’s knowledge, attitudes and perceptions towards the COVID-19 vaccine and vaccination rollout. This paper presents findings from a novel study conducted to assess the knowledge, attitudes and perceptions towards COVID-19 vaccinations in Bangladesh. The findings reflect a large number of socio-demographic factors influencing knowledge, attitudes and perceptions towards COVID-19 vaccinations and therefore our findings will be crucial in developing COVID-19 vaccination related awareness and health education programs.
The knowledge regarding COVID-19 vaccinations was low among more than half of the population. In this study, knowledge was significantly associated with education, family type, monthly income of a family, and previous vaccine uptake experience. However, attitudes were significantly associated with only sex and earlier vaccine administration experience. Importantly, the majority of participants (78%) showed positive attitude towards COVID-19 vaccine. Knowledge regarding COVID-19 vaccinations was not significant in terms of participants’ sex. This finding is similar with other studies in Bangladesh demonstrating no significant sex differences in knowledge regarding COVID-19 [
26,
27]. This finding is similar to studies concerning knowledge towards COVID-19 (not vaccinations) conducted in Bangladesh which reported that males had marginally higher scores in knowledge regarding COVID-19 than females [
28,
29]. However, this finding is inconsistent to studies concerning knowledge towards COVID-19 (not vaccinations) conducted in Bangladesh which reported that males had marginally higher scores in knowledge regarding COVID-19 than females [
28,
29]. These discrepancies of knowledge found in our study on COVID-19 vaccinations are possibly due to limited government exposures to information or publicity on COVID-19 vaccinations since the vaccine rollout started. In addition, the potential under-reporting or misinformation of data on the seriousness of incidence and mortality of COVID-19 may reduce concerns about vaccine safety [
30] or indeed make residents of Bangladesh reluctant to seek information on either COVID-19 or related vaccinations. Thus, it is essential to support community members by providing easy access to trusted, evidence-based vaccine information.
According to our study, participants with a higher level of education were found to have more knowledge about COVID-19 vaccinations, which is also supported by previous research. Similar scenarios were found in other earlier studies in Bangladesh, illustrating that individuals with a higher educational background showed more knowledge regarding COVID-19 [
27,
31]. It may be the case that more educated people are more knowledgeable and concerned about their health and well-being, through access to more information sources, and become more engaged in life events that could impact them [
32], such as COVID-19 vaccinations.
Significant associations were found between living in a nuclear family and knowledge regarding COVID-19 vaccinations. This is not supported by a preceding study in the same country regarding knowledge about cholera and oral cholera vaccine, where no significant association between knowledge and family type was found [
33]. People in the upper SES group had more knowledge regarding COVID-19 vaccinations, which is similar to a study conducted in Indonesia to assess Dengue vaccine acceptance [
34]. Moreover, a study carried out among Bangladeshi women regarding knowledge of cervical cancer and human papillomavirus (HPV) vaccine also supports this SES current association [
35].
People who have received any vaccine earlier were found to have more knowledge regarding COVID-19 vaccinations in this study. A recent study in China evaluating COVID-19 vaccine acceptance found that people who were previously vaccinated against influenza were more likely to accept the COVID-19 vaccine [
36], which was also demonstrated in a study in Hong Kong [
7]. This tendency among people may be due to previous positive experiences from vaccination. The level of knowledge about COVID-19 vaccinations was significantly higher among people living in the urban areas, compared to rural areas. However, this association didn’t retain in multiple regression. This is supported by an earlier study in Bangladesh which demonstrated significant correlation between COVID-19 knowledge and urban location [
28]. However, our finding is inconsistent with a recent study which found more accurate knowledge about COVID-19 among people in rural areas in Bangladesh [
26].
In the present study, 78% of participants had more positive attitudes towards COVID-19 vaccine, which was significantly associated with being female. This association is in line with a previous study on attitudes towards dengue vaccination conducted in Indonesia [
37] and attitudes towards COVID-19 carried out in Bangladesh [
26]. Attitude towards COVID-19 vaccinations in another study found that female’s hesitation towards COVID-19 vaccinations was higher than that for males [
38]. However, a study in China found that male participants were more likely to accept the COVID-19 vaccine [
36]. Worldwide, there is a broadly gendered notion that women’s positive attitudes towards preventive measures are higher than men [
26], and this result can be important because engaging women in household-level education and encouragement of COVID-19 vaccination could eventually lead to the improvement in vaccination programs. In addition, in our study, participants who received all the recommended vaccines earlier in life showed more positive attitudes towards COVID-19 vaccinations. Our finding is similar to a study in Hong Kong which demonstrated that the key factors influencing the willingness to receive the A/H7N9 influenza vaccine have been previous vaccine uptake history [
7], which is also supported by an earlier study in China [
36].
Our study found that over half (52%) of the participants thought that everyone should get COVID-19 vaccine in Bangladesh. Furthermore, more than half of the participants (61%) thought health workers should get the vaccine first. This perception might be because health care workers are at the frontline to diagnose with COVID-19 as they have to deal with patients regularly. In contrast to the general population, the probability of reporting a positive COVID-19 test was higher for frontline health workers [
39]. Moreover, their family members are also at high risk, which may lead to rapid transmission among communities.
In our study, 89% of participants assumed that the recently developed COVID-19 vaccine (the vaccine currently being used in Bangladesh) could have some side effects, which is similar to a study in the United States [
38]. This may be linked to rumors and misleading information which are spread in mass and social media and facilitates vaccine hesitancy and refusal [
40‐
42]. A previous study also reported that vaccine hesitancy and refusal are associated with both misinformation on social media and attitudes about a particular illness not being preventable via a vaccine [
43]. A study in China found that 48% of respondents postponed vaccination before confirmation of the safety of the vaccine [
36], which shows their doubt regarding vaccine safety. Worryingly, the exceptionally rapid pace of vaccine development, the skepticism of certain groups of science and health experts might elevate doubt about COVID-19 vaccine [
44]. According to our study, 95% participants reported that the vaccine should be free for people in Bangladesh, which is inconsistent with a previous study in Indonesia, where most of the respondents were willing to pay for the COVID-19 vaccine [
45]. Another study also demonstrated that participants were willing to pay for the COVID-19 vaccine (US$11.5 to US$23) [
46]. Additionally, a survey in Ecuador also showed 85% of the respondents were willing to pay for COVID-19 vaccination [
47]. This difference from the other countries may reflect the financial condition of a large proportion of Bangladeshi people, compounded by the fact that lots of people have lost their livelihood during COVID-19 lockdowns and quarantines, which has also contributed to unemployment, hunger, starvation and social disputes [
48] which resulted in low ability to pay for COVID-19 vaccine among mass people.
Limitations
There are certain limitations that should be addressed in the interpretation of the findings from this study. Firstly, the study was cross-sectional, so the causality cannot be attributed to the findings in the regression models and the findings may not be generalizable over time. In this respect, a longitudinal study is important. Secondly, the study used an online self-reporting method that may be exposed to social acceptability and memory biases. Thirdly, the study utilized snowballing sampling technique that may result in selection bias. So, a further study with random sampling technique is warranted. However, the survey was performed prior to the mass vaccination period in Bangladesh, and its findings may vary after the vaccination program has been implemented. Nevertheless, this is the first study of community perceptions about COVID-19 vaccinations in Bangladesh and will be crucial for health policy makers and planners who are aiming to vaccinate the highest proportion of the population possible in order to mitigate the impacts of the pandemic.
Acknowledgments
Firstly, the authors would like to express the most profound gratitude to all of the respondents who participated in this study. The authors would like to thank all research assistants: Mst. Shauda Ahmed, Jannatul Mawa, Amena Akhter, Md. Mehedy Hassan, Sharin Siddika Chaity, Md. Jahid Hasan, Md Tariq Ahmed, Mintia Islam Austha, Md. Mirazul Islam, Md. Al Amin, Asif Mahmud Arnob, Shazid Hossain Adib, Mashrafi Nayeem, Tanoy Chandra Bhowmick, Irfanul Haque Nabil, Mst. Jemi Hkatun, Md. Kamrul Hasan Shaowkat, Sheikh Hafsa Boqul, Shahrina Tasnim Manami, Sangita Chakraborty, Nowshin Nabila Siddique, Imtiaz Ahmed Sakib, and Umma Motahara, for their supports during the study periods.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.